Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) Net Income Growth (3y) (2012 - 2026)

Analysis

Thermo Fisher Scientific (TMO) Net Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 8.44%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -7.69%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 48.30%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 42.35%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 13.37%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 6.14%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 32.37%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -36.74%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 34.02%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -54.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 8.44%
Mar 28, 2026 8.11%
Dec 31, 2025 7.63%
Sep 27, 2025 1.03%
Jun 28, 2025 -2.02%
Mar 29, 2025 -12.02%
Dec 31, 2024 2.58%
Sep 28, 2024 -4.83%
Jun 29, 2024 -3.65%
Mar 30, 2024 -17.59%
Dec 31, 2023 -13.73%
Sep 30, 2023 -3.97%
Jul 1, 2023 6.03%
Apr 1, 2023 18.67%
Dec 31, 2022 16.90%
Oct 1, 2022 27.36%
Jul 2, 2022 15.38%
Apr 2, 2022 40.06%
Dec 31, 2021 22.70%
Oct 2, 2021 39.05%